Medidata's 2014 guidance causes shares to dip; Qlucore and Nebion cross-promoting bioinformatics tools;

> Medidata ($MDSO) shares fell after the company posted 2014 guidance that fell short of analyst expectations. Results

> Bioinformatics firms Qlucore and Nebion are to promote each other's data analysis products. Article (reg. req.)

> BioClinica ($BIOC) could double its presence in Europe this year after strong performance in 2013. Release

> Texas A&M is using Datatrak's eClinical software for preclinical projects. Item

> Tech-focused CRO Clinipace reports it doubled its booking last year compared to 2012. News

> FDA surveys show changes to its website's search function have increased visitor satisfaction. Post

> Accelrys ($ACCL) has introduced a cloud-based drug discovery collaboration platform. Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.